Research study Program year 2024 Source: CMS Open Payments

M23-700 Upa Phase 4 RA Select Switch

ClinicalTrials.gov NCT05814627

Research payments

$1,675

8 payments

Through program year 2024, $1,675 in research payments was reported against M23-700 Upa Phase 4 RA Select Switch, across 8 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT05814627

By program year

1 row

Year	Kind	Amount	Payments
2024	Research	$1,675	8

Breakdown

Who paid Research payments · program year 2024

AbbVie, Inc. $1,675 8 payments

Who received the money Research payments · program year 2024

Trinity Universal Research Associat Organisation paid for research $673 2 payments
Valerius Medical Group And Research Organisation paid for research $386 1 payment
Baycare Health System INC Organisation paid for research $251 1 payment
Deerbrook Medical Associates Organisation paid for research $173 1 payment
Research Physicians Network LLC Organisation paid for research $70 1 payment
West Texas Clinical Research Organisation paid for research $70 1 payment
Tchd D/B/A Jps Health Network Teaching hospital · TX $51 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.